These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37165519)

  • 61. Aqueous Humour Cytokine Changes with Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema.
    Figueras-Roca M; Sala-Puigdollers A; Alforja S; Torras J; Peraza-Nieves J; Zarranz-Ventura J; Adan Civera A; Molins B
    Ocul Immunol Inflamm; 2019; 27(8):1203-1210. PubMed ID: 31418610
    [No Abstract]   [Full Text] [Related]  

  • 62. Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Singer MA; Capone A; Dugel PU; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Apr; 15():33. PubMed ID: 25885285
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial.
    Mehta H; Fraser-Bell S; Yeung A; Campain A; Lim LL; Quin GJ; McAllister IL; Keane PA; Gillies MC
    Br J Ophthalmol; 2016 Jul; 100(7):1000-1004. PubMed ID: 26537156
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Safety of 6000 intravitreal dexamethasone implants.
    Rajesh B; Zarranz-Ventura J; Fung AT; Busch C; Sahoo NK; Rodriguez-Valdes PJ; Sarao V; Mishra SK; Saatci AO; Udaondo Mirete P; Querques G; Farah ME; Lanzetta P; Arevalo JF; Kodjikian L; Chhablani J;
    Br J Ophthalmol; 2020 Jan; 104(1):39-46. PubMed ID: 31040132
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-term follow-up of diabetic macular edema treated with dexamethasone implant: a real-life study.
    Mathis T; Lereuil T; Abukashabah A; Voirin N; Sudhalkar A; Bilgic A; Denis P; Dot C; Kodjikian L
    Acta Diabetol; 2020 Dec; 57(12):1413-1421. PubMed ID: 32656710
    [TBL] [Abstract][Full Text] [Related]  

  • 66. OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS.
    Reid GA; Sahota DS; Sarhan M
    Retina; 2015 Aug; 35(8):1647-55. PubMed ID: 25932545
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dexamethasone intravitreal implant in patients with cataract and naïve diabetic macular edema.
    Barone A; Russo V; Maggiore G; Loiodice MS; Stella A; Bux AV; Iaculli C
    Eur J Ophthalmol; 2022 Jan; 32(1):364-371. PubMed ID: 33757366
    [TBL] [Abstract][Full Text] [Related]  

  • 68. PERSISTENT REMNANTS OF DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX).
    Kim JT; Lee SH; Choi SU
    Retina; 2020 Nov; 40(11):2226-2231. PubMed ID: 32058420
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A Clinical Trial Comparing Ozurdex Sustained Release Dexamethasone Intravitreal Implant and Bevacizumab Treatment for Diabetic Macular Edema.
    Aroney C; Fraser-Bell S; Lamoureux EL; Gillies MC; Lim LL; Fenwick EK
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5541-5546. PubMed ID: 27768792
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Accidental Intralenticular Injection of Ozurdex® for Branch Retinal Vein Occlusion: Intact Posterior Capsule and Resolution of Macular Edema.
    Kurt A; Durukan AH; Küçükevcilioğlu M
    Case Rep Ophthalmol Med; 2019; 2019():8630504. PubMed ID: 30809404
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantification of fluid resorption from diabetic macular oedema with foveal serous detachment after dexamethasone intravitreal implant (Ozurdex
    Hodzic-Hadzibegovic D; Ba-Ali S; Valerius M; Lund-Andersen H
    Acta Ophthalmol; 2017 May; 95(3):324-325. PubMed ID: 27778454
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of intravitreal dexamethasone implant and anti-VEGF drugs in the treatment of retinal vein occlusion-induced oedema: a meta-analysis and systematic review.
    Ming S; Xie K; Yang M; He H; Li Y; Lei B
    BMJ Open; 2020 Jun; 10(6):e032128. PubMed ID: 32595145
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ozurdex for refractory macular edema secondary to diabetes, vein occlusion, uveitis and pseudophakia.
    Teja S; Sawatzky L; Wiens T; Maberley D; Ma P
    Can J Ophthalmol; 2019 Oct; 54(5):540-547. PubMed ID: 31564342
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety and Efficacy of Intravitreal Dexamethasone Implant for Refractory Uveitic Macular Edema in Adults and Children.
    Ratra D; Barh A; Banerjee M; Ratra V; Biswas J
    Ocul Immunol Inflamm; 2018; 26(7):1034-1040. PubMed ID: 29394119
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Lee KH; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dexamethasone intravitreal implant for diabetic macular edema: indications for a PRN regimen of treatment.
    Panozzo G; Gusson E; Panozzo G; Dalla Mura G
    Eur J Ophthalmol; 2015; 25(4):347-51. PubMed ID: 25633618
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema.
    Vaz-Pereira S; Castro-de-Sousa JP; Martins D; Prates Canelas J; Reis P; Sampaio A; Urbano H; Kaku P; Nascimento J; Marques-Neves C
    Ophthalmic Res; 2020; 63(2):114-121. PubMed ID: 31801148
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Difference in the efficacy of intravitreal dexamethasone implant before and after silicone oil removal: A case report.
    An JH; Kim YC
    Medicine (Baltimore); 2021 Mar; 100(11):e25161. PubMed ID: 33726001
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intravitreal dexamethasone implant for macular edema following uncomplicated phacoemulsification.
    Furino C; Boscia F; Recchimurzo N; Sborgia C; Alessio G
    Eur J Ophthalmol; 2014; 24(3):387-91. PubMed ID: 24170523
    [TBL] [Abstract][Full Text] [Related]  

  • 80. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.
    Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF;
    Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.